452 related articles for article (PubMed ID: 25553105)
1. Macrophage targeted theranostics as personalized nanomedicine strategies for inflammatory diseases.
Patel SK; Janjic JM
Theranostics; 2015; 5(2):150-72. PubMed ID: 25553105
[TBL] [Abstract][Full Text] [Related]
2. Theranostics - a sure cure for cancer after 100 years?
Song Y; Zou J; Castellanos EA; Matsuura N; Ronald JA; Shuhendler A; Weber WA; Gilad AA; Müller C; Witney TH; Chen X
Theranostics; 2024; 14(6):2464-2488. PubMed ID: 38646648
[TBL] [Abstract][Full Text] [Related]
3. Theranostic nanomedicine.
Lammers T; Aime S; Hennink WE; Storm G; Kiessling F
Acc Chem Res; 2011 Oct; 44(10):1029-38. PubMed ID: 21545096
[TBL] [Abstract][Full Text] [Related]
4. Are nanotheranostics and nanodiagnostics-guided drug delivery stepping stones towards precision medicine?
Blau R; Krivitsky A; Epshtein Y; Satchi-Fainaro R
Drug Resist Updat; 2016 Jul; 27():39-58. PubMed ID: 27449597
[TBL] [Abstract][Full Text] [Related]
5. Nanomedicine strategies for molecular targets with MRI and optical imaging.
Pan D; Caruthers SD; Chen J; Winter PM; SenPan A; Schmieder AH; Wickline SA; Lanza GM
Future Med Chem; 2010 Mar; 2(3):471-90. PubMed ID: 20485473
[TBL] [Abstract][Full Text] [Related]
6. Anti-cancer precision theranostics: a focus on multifunctional gold nanoparticles.
Cabral RM; Baptista PV
Expert Rev Mol Diagn; 2014 Nov; 14(8):1041-52. PubMed ID: 25314939
[TBL] [Abstract][Full Text] [Related]
7. Unique roles of nanotechnology in medicine and cancer.
Alam F; Naim M; Aziz M; Yadav N
Indian J Cancer; 2014; 51(4):506-10. PubMed ID: 26842179
[TBL] [Abstract][Full Text] [Related]
8. Nanomaterial applications in multiple sclerosis inflamed brain.
Ballerini C; Baldi G; Aldinucci A; Maggi P
J Neuroimmune Pharmacol; 2015 Mar; 10(1):1-13. PubMed ID: 25616566
[TBL] [Abstract][Full Text] [Related]
9. Nanomedicines for dysfunctional macrophage-associated diseases.
He H; Ghosh S; Yang H
J Control Release; 2017 Feb; 247():106-126. PubMed ID: 28057522
[TBL] [Abstract][Full Text] [Related]
10. Self-assembling nanoclusters in living systems: application for integrated photothermal nanodiagnostics and nanotherapy.
Zharov VP; Kim JW; Curiel DT; Everts M
Nanomedicine; 2005 Dec; 1(4):326-45. PubMed ID: 17292107
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional nanoparticles for targeting cancer and inflammatory diseases.
Jain S; Doshi AS; Iyer AK; Amiji MM
J Drug Target; 2013 Dec; 21(10):888-903. PubMed ID: 24024598
[TBL] [Abstract][Full Text] [Related]
12. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
Zhu L; Zhou Z; Mao H; Yang L
Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography image-guided drug delivery: current status and future perspectives.
Chakravarty R; Hong H; Cai W
Mol Pharm; 2014 Nov; 11(11):3777-97. PubMed ID: 24865108
[TBL] [Abstract][Full Text] [Related]
14. Cysteine cathepsins as therapeutic targets in inflammatory diseases.
Vizovišek M; Vidak E; Javoršek U; Mikhaylov G; Bratovš A; Turk B
Expert Opin Ther Targets; 2020 Jun; 24(6):573-588. PubMed ID: 32228244
[No Abstract] [Full Text] [Related]
15. Applying nanomedicine in maladaptive inflammation and angiogenesis.
Alaarg A; Pérez-Medina C; Metselaar JM; Nahrendorf M; Fayad ZA; Storm G; Mulder WJM
Adv Drug Deliv Rev; 2017 Sep; 119():143-158. PubMed ID: 28506745
[TBL] [Abstract][Full Text] [Related]
16. Image-guided drug delivery: preclinical applications and clinical translation.
Ojha T; Rizzo L; Storm G; Kiessling F; Lammers T
Expert Opin Drug Deliv; 2015 Aug; 12(8):1203-7. PubMed ID: 26083469
[TBL] [Abstract][Full Text] [Related]
17. Versatile Nanosystem-Based Cancer Theranostics: Design Inspiration and Predetermined Routing.
Opoku-Damoah Y; Wang R; Zhou J; Ding Y
Theranostics; 2016; 6(7):986-1003. PubMed ID: 27217832
[TBL] [Abstract][Full Text] [Related]
18. Targeting Macrophages as a Potential Therapeutic Intervention: Impact on Inflammatory Diseases and Cancer.
Ponzoni M; Pastorino F; Di Paolo D; Perri P; Brignole C
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29973487
[TBL] [Abstract][Full Text] [Related]
19. Advancements in Macrophage-Targeted Drug Delivery for Effective Disease Management.
Liu H; Lv H; Duan X; Du Y; Tang Y; Xu W
Int J Nanomedicine; 2023; 18():6915-6940. PubMed ID: 38026516
[TBL] [Abstract][Full Text] [Related]
20. Imaging and nanomedicine in inflammatory atherosclerosis.
Mulder WJ; Jaffer FA; Fayad ZA; Nahrendorf M
Sci Transl Med; 2014 Jun; 6(239):239sr1. PubMed ID: 24898749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
